Adaptation of the Hepatitis B Virus Core Protein to CD8+ T-Cell Selection Pressure

Hepatology

Volumn 62, Issue 1, 2015, Pages 47-56

  Kefalakes, Helenie ^a   Budeus, Bettina ^a   Walker, Andreas ^a   Jochum, Christoph ^a   Hilgard, Gudrun ^a   Heinold, Andreas ^a   Heinemann, Falko M ^a   Gerken, Guido ^a   Hoffmann, Daniel ^a   Timm, Joerg ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CORE PROTEIN; HEPATITIS B(E) ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; THREONINE; EPITOPE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CD8 CELL SELECTION; CD8+ T LYMPHOCYTE; CELL SELECTION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DISEASE SEVERITY; EX VIVO STUDY; GENE AMPLIFICATION; GENE SEQUENCE; HEPATITIS B VIRUS GENOTYPE A; HEPATITIS B VIRUS GENOTYPE D; HLA TYPING; HUMAN; HUMAN CELL; IMMUNE EVASION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; VIRUS CORE; VIRUS GENE; VIRUS MUTATION; VIRUS REPLICATION; ADAPTATION; GENE; GENETIC SELECTION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

ADAPTATION, BIOLOGICAL; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; GENES, MHC CLASS I; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; SELECTION, GENETIC; VIRAL CORE PROTEINS;

EID: 84932601095     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27771     Document Type: Article

References (28)

1. Michel ML, Deng Q, Mancini-Bourgine M. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges. J Hepatol 2011;54:1286-1296.
2. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-229.
3. Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, Brendish N, et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009;137:1289-1300.
4. Carlson JM, Le AQ, Shahid A, Brumme ZL. HIV-1 adaptation to HLA: a window into virus-host immune interactions. Trends Microbiol 2015; doi: 10.1016/j.tim.2014.12.008.
5. + T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infections. Med Microbiol Immunol 2015;204:29-38.
6. Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A, et al. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 1994;180:933-943.
7. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994;369:407-410.
8. Rehermann B, Pasquinelli C, Mosier SM, Chisari FV. Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J Clin Invest 1995;96:1527-1534.
9. Desmond CP, Gaudieri S, James IR, Pfafferott K, Chopra A, Lau GK, et al. Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease. J Virol 2012;86:1181-1192.
10. Abbott WG, Tsai P, Leung E, Trevarton A, Ofanoa M, Hornell J, et al. Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans. J Virol 2010;84:621-629.
11. Heinemann FM. HLA Genotyping and antibody characterization using the luminex multiplex technology. Transfus Med Hemother 2009;36:273-278.
12. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995;57:289-300.
13. + T-cell response in vitro in patients coinfected with HIV-1. AIDS 2012;26:2145-2153.
14. Carlson JM, Brumme CJ, Martin E, Listgarten J, Brockman MA, Le AQ, et al. Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. J Virol 2012;86:13202-13216.
15. +)-cell responses to vaccinia virus. Nat Biotechnol 2006;24:817-819.
16. Muller CR, Ehninger G, Goldmann SF. Gene and haplotype frequencies for the loci hLA-A, hLA-B, and hLA-DR based on over 13, 000 german blood donors. Hum Immunol 2003;64:137-151.
17. Tan AT, Loggi E, Boni C, Chia A, Gehring AJ, Sastry KS, et al. Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol 2008;82:10986-10997.
18. + T cell epitope. J Hepatol 2014;60:22-29.
19. Heidrich B, Cetindere A, Beyaz M, Basaran MM, Braynis B, Raupach R, et al. High prevalence of hepatitis marker in immigrant populations: a prospective multicenter screening approach in a real world setting. J Hepatol 2012;56:S386.
20. Bhattacharya T, Daniels M, Heckerman D, Foley B, Frahm N, Kadie C, et al. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 2007;315:1583-1586.
21. Bertoni R, Sidney J, Fowler P, Chesnut RW, Chisari FV, Sette A. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 1997;100:503-513.
22. Tan AT, Sodsai P, Chia A, Moreau E, Chng MH, Tham CY, et al. Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region. J Virol 2014;88:1332-1341.
23. Timm J, Li B, Daniels MG, Bhattacharya T, Reyor LL, Allgaier R, et al. Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology 2007;46:339-349.
24. Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest 1992;89:87-96.
25. + T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. J Hepatol 2014;61:1212-1219.
26. Bozkaya H, Ayola B, Lok AS. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection. Hepatology 1996;24:32-37.
27. Hannoun C, Horal P, Lindh M. Long-term mutation rates in the hepatitis B virus genome. J Gen Virol 2000;81:75-83.
28. Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY. Molecular evolution of hepatitis B virus over 25 years. J Virol 2006;80:10307-10314.